Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating) was the target of a large decline in short interest during the month of February. As of February 15th, there was short interest totalling 960,000 shares, a decline of 53.2% from the January 31st total of 2,050,000 shares. Based on an average trading volume of 151,900 shares, the […]